Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,021Revenue $M13.9Net Margin (%)-235.2Z-Score8.5
Enterprise Value $M2,930EPS $-1.2Operating Margin %-143.2F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-241.6Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %0Quick Ratio4.2Cash flow > EarningsN
Price/Sales64.25-y EBITDA Growth Rate %0Current Ratio4.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-29.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M101ROI % (ttm)-110.7Gross Margin Increase y-yN

Gurus Latest Trades with XON

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XONDavid Einhorn 2014-09-30 Reduce-0.06%$17.86 - $26.59
($21.29)
$ 30.0541%Reduce -47.39%197,278
XONJean-Marie Eveillard 2014-06-30 Buy 0.04%$15.3 - $25.93
($21.15)
$ 30.0542%New holding, 661564 sh.661,564
XONDavid Einhorn 2014-06-30 Reduce-0.39%$15.3 - $25.93
($21.15)
$ 30.0542%Reduce -72.81%375,000
XONDaniel Loeb 2014-03-31 Add0.18%$22.5 - $36.82
($28.82)
$ 30.054%Add 18.15%3,000,000
XONDavid Einhorn 2014-03-31 Reduce-0.26%$22.5 - $36.82
($28.82)
$ 30.054%Reduce -37.58%1,379,014
XONDaniel Loeb 2013-12-31 Add0.15%$17.65 - $25.5
($21.05)
$ 30.0543%Add 18.07%2,539,200
XONT Boone Pickens 2013-12-31 Sold Out -0.47%$17.65 - $25.5
($21.05)
$ 30.0543%Sold Out0
XONDaniel Loeb 2013-09-30 Buy 1.2%$21.36 - $29.7
($24.16)
$ 30.0524%New holding, 2150592 sh.2,150,592
XONDavid Einhorn 2013-09-30 Buy 0.86%$21.36 - $29.7
($24.16)
$ 30.0524%New holding, 2176868 sh.2,176,868
XONT Boone Pickens 2013-09-30 Buy 0.47%$21.36 - $29.7
($24.16)
$ 30.0524%New holding, 12000 sh.12,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XON is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
XON Jean-Marie Eveillard 2014-09-30790,3640.790.04+19.47%
XON Daniel Loeb 2014-09-302,900,0002.880.62
XON David Einhorn 2014-09-30197,2780.20.05-47.39%
Premium Most recent portfolio changes are included for Premium Members only!


XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JCEO, 10% Owner 2015-01-27Buy555,556$2714.96view
Reed Thomas D.Chief Science Officer 2014-05-13Buy640$15.698.97view
Lehr Donald P.Chief Legal Officer 2014-05-13Buy1,850$15.9994.12view
KIRK RANDAL JCEO, 10% Owner 2014-05-13Buy65,173$15.19104.34view
Krishnan Krish SCOO 2014-05-09Buy20,900$14.21118.44view
KIRK RANDAL JCEO, 10% Owner 2014-05-09Buy67,333$15.16104.75view
Krishnan SumaSVP--Product Development 2014-05-09Buy20,900$14.21118.44view
Huang KellySVP-Consumer Sector 2014-05-09Buy3,200$15.7896.7view
Kasser Thomas R.SVP--Food Sector 2014-05-09Buy10,000$13.39131.81view
KIRK RANDAL JCEO, 10% Owner 2014-03-27Buy243,001$25.7220.68view

Press Releases about XON :

    Quarterly/Annual Reports about XON:

    News about XON:

    Articles On GuruFocus.com
    5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 20 2014 
    Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
    Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
    David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 
    Weekly CEO Buys Highlight: XON, ARCP, FSFR, CNTY, RHP Aug 18 2013 

    More From Other Websites
    Intrexon Announces Closing of $116 Million Public Offering of Common Stock including Full Exercise... Jan 27 2015
    Intrexon Announces Closing of $116 Million Public Offering of Common Stock including Full Exercise... Jan 27 2015
    Intrexon to Acquire Remaining Stake in Exemplar Genetics Jan 26 2015
    8:32 am Intrexon to acquire remaining stake in Exemplar Genetics; terms not disclosed Jan 26 2015
    Intrexon to Acquire Remaining Stake in Exemplar Genetics Jan 26 2015
    INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Jan 22 2015
    Intrexon (XON) Stock Falls After Pricing Public Offering Jan 22 2015
    Intrexon Prices Public Offering of Common Stock Jan 21 2015
    Intrexon Prices Public Offering of Common Stock Jan 21 2015
    4 More Biotech Secondaries Traders Are Watching Jan 21 2015
    INTREXON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 20 2015
    Intrexon Announces Proposed Public Offering of Common Stock Jan 20 2015
    Intrexon Announces Proposed Public Offering of Common Stock Jan 20 2015
    ZIOPHARM, Intrexon Ink CAR T Deal with MD Anderson - Analyst Blog Jan 16 2015
    Intrexon, ZIOPHARM, and MD Anderson in Exclusive CAR T Pact Jan 15 2015
    Intrexon (XON) Worth Watching: Stock Adds 31.5% in Session - Tale of the Tape Jan 15 2015
    Did Ziopharm and Intrexon Run Too Much on an MD Anderson Pact? Jan 14 2015
    INTREXON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 14 2015
    BUZZ-U.S. STOCKS ON THE MOVE-JPMorgan, AstraZeneca, Ziopharm, Intrexon Jan 14 2015
    Intrexon, ZIOPHARM, and MD Anderson in Exclusive CAR T Pact Jan 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK